Clinical Trial Update: Efficacy and Safety on SOM3355 in Huntington's Disease Chorea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of SOM3355 in Huntington's disease chorea has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• SOM3355

Snippet

Sponsor: SOM Innovation Biotech SA | Conditions: Huntington Chorea | Phase 2 | Status: COMPLETED | Results posted: 2025-08-28